Allopurinol (4-hydroxypyrazolo-(3, 4-d) pyrimidine, HPP), a xanthine oxidase inhibitor, offers a new concept in the prevention of the complications of hyperuricemia. By effectively blocking the ...
Our intervention reduced the proportion of patients with prescriptions exceeding the recommended maximum daily dose, with a trend in reducing the proportion of patients with at least one ...
Patients with renal disease have reduced uric acid excretion, a problem that can cause kidney function to deteriorate even further. Results of a prospective, randomized, controlled trial indicate ...
Febuxostat 40 mg daily appears to be as efficacious as allopurinol in lowering serum uric acid levels. [38] Both febuxostat 40 and 80 mg can be given to patients with mild-to-moderate renal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results